Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 21 Issue 8, August 2020

Sustaining T cell preparedness

Geiger and colleagues use SILAC and mass spectrometry to study protein turnover in human T cells and examine how naive T cells both maintain their quiescence and transition to activated cells.

See article Geiger and N&Vs Cantrell

IMAGE: Tim Beltraminelli, Christopher K.E. Bleck, Dirk Bumann, Roger Geiger. COVER DESIGN: Erin Dewalt.

World View

Top of page ⤴

Comment

Top of page ⤴

News & Views

  • CAR T cells are engineered to recognize tumor-specific antigens and kill tumor cells. A study of CAR T cell activation using single-molecule microscopy reveals that CARs fail to efficiently convert antigen binding into early T cell signaling events.

    • Björn F. Lillemeier
    News & Views
  • A new report finds that peripheral immunization generates tissue-resident memory CD8+ T cells in the central nervous system that provide robust protection against local infection.

    • Michael A. Kovacs
    • Tajie H. Harris
    News & Views
  • Quantitative systems-level proteomics is cleverly used to reveal a dynamic program of protein turnover in naive and memory CD4+ T cells that, alongside a stockpile of metabolic protein machinery, poises the cells for activation.

    • Julia M. Marchingo
    • Doreen A. Cantrell
    News & Views
  • Guanylate-binding proteins (GBPs) promote immune defenses against infectious agents. Two studies reveal that GBP1 directly binds to cytosolic lipopolysaccharide (LPS), bringing caspase-4 to the surface of bacteria to induce pyroptosis.

    • Shouya Feng
    • Si Ming Man
    News & Views
  • Antigen escape by solid tumors has limited the efficacy of genetically modified T cells. T cells engineered to secrete the cytokine Flt3L induce the activation of endogenous T cells, enabling a broader repertoire of tumor antigens to be targeted via the expansion of intratumoral antigen presenting cells, significantly improving tumor responses.

    • Emma C. Morris
    News & Views
  • Evolutionary genetic and experimental analyses suggest that mutations causing familial Mediterranean fever have been positively selected in the Middle East, probably because they confer heightened resistance against Yersinia pestis infection.

    • Etienne Patin
    News & Views
Top of page ⤴

Review Articles

Top of page ⤴

Letters

  • Huppa and colleagues highlight signaling deficiencies in chimeric antigen receptor (CAR)-modified T cells that limit the efficacy of CAR T cell therapies to target tumors with diminished antigen expression.

    • Venugopal Gudipati
    • Julian Rydzek
    • Johannes B. Huppa
    Letter
Top of page ⤴

Articles

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links